Telesis Bio, Inc. (TBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0220
+0.0010 (4.76%)
At close: Dec 5, 2025
Telesis Bio Market Cap
Telesis Bio has a market cap or net worth of $39.64 thousand as of December 5, 2025. Its market cap has decreased by -99.39% in one year.
Market Cap
39.64K
Enterprise Value
42.91M
Revenue
17.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since June 18, 2021, Telesis Bio's market cap has decreased from 522.24M to 39.64K, a decrease of -99.99%. That is a compound annual growth rate of -88.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 39.64K | -94.42% |
| Dec 31, 2024 | 710.34K | -94.06% |
| Dec 29, 2023 | 11.96M | -66.23% |
| Dec 30, 2022 | 35.43M | -88.81% |
| Dec 31, 2021 | 316.52M | -39.39% |
| Jun 18, 2021 | 522.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 569.32M |
| Glass House Brands | 503.27M |
| CytoDyn | 416.55M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 359.36M |
| Silence Therapeutics | 298.99M |
| Nika Pharmaceuticals | 259.91M |